期刊
MOLECULAR BIOLOGY
卷 47, 期 5, 页码 733-742出版社
MAIK NAUKA/INTERPERIODICA/SPRINGER
DOI: 10.1134/S0026893313050075
关键词
apoptin; transient dominant selection; recombinant vaccinia virus; virus growth factor; puromycin; oncolytic activity
资金
- Government of the Russian Federation [11.G34.31.0034]
- State Program for the Support of Leading Scientific Schools [NSh 2996.2012.4]
- Federal Target Program Human Resources in Science and Teaching in Innovative Russia [14.V37.21.1972]
- Federal Target Program Research and Development in Priority Areas of the Science and Technology Complex of Russia [14.512.11.0002]
The chicken anemia virus gene that encodes apoptin, a selective killer of cancer cells, was synthe-sized and inserted into the vaccinia virus (strain L-IVP) genome. The insertion replaces a major part of the viral C11R gene that encodes viral growth factor, which is important for virulence. The recombinant virus VVdGF-ApoS24/2 was obtained by transient dominant selection using the gene of puromycin resistance as a selective marker. The expression of the apoptin gene from a synthetic early-late promoter of vaccinia virus ensured the efficient accumulation of the target protein in VVdGF-ApoS24/2-infected cells. Although recombinant apoptin carried the signal peptide of the virus growth factor at the N-end, the protein was not secreted into the culture medium. The recombinant virus VVdGF-ApoS24/2 exhibited significantly higher selective lytic activity in human cancer cell lines (A549, A431, U87MG, RD, and MCF7) than the parent strain L-IVP and its VVdGF2/6 variant with C11R deletion. These results suggest that the use of apoptin can be an efficient means of enhancing the natural anticancer activity of vaccinia virus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据